These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34250945)

  • 41. Dependent and paranoid personality patterns in myotonic dystrophy type 1.
    Peric S; Sreckov M; Basta I; Lavrnic D; Vujnic M; Marjanovic I; Rakocevic Stojanovic V
    Acta Neurol Scand; 2014 Apr; 129(4):219-25. PubMed ID: 24032453
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Educational and Professional Qualifications of Adults With Myotonic Dystrophies - A Misleading Perception by the Myopathic Face?].
    Stahl K; Wenninger S; Schüller A; Montagnese F; Schoser B
    Fortschr Neurol Psychiatr; 2016 Apr; 84(4):211-6. PubMed ID: 27100845
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Myotonic dystrophy health index: Correlations with clinical tests and patient function.
    Heatwole C; Bode R; Johnson NE; Dekdebrun J; Dilek N; Eichinger K; Hilbert JE; Logigian E; Luebbe E; Martens W; Mcdermott MP; Pandya S; Puwanant A; Rothrock N; Thornton C; Vickrey BG; Victorson D; Moxley RT
    Muscle Nerve; 2016 Feb; 53(2):183-90. PubMed ID: 26044513
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Caregiver Burden and Related Factors Among Caregivers of Patients with Myotonic Dystrophy Type 1.
    Kurauchi G; Endo M; Odaira K; Ono R; Koseki A; Goto M; Sato Y; Kon S; Watanabe N; Sugawara N; Kimura E; Takada H
    J Neuromuscul Dis; 2019; 6(4):527-536. PubMed ID: 31640106
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High incidence of falls in patients with myotonic dystrophy type 1 and 2: A prospective study.
    Berends J; Tieleman AA; Horlings CGC; Smulders FHP; Voermans NC; van Engelen BGM; Raaphorst J
    Neuromuscul Disord; 2019 Oct; 29(10):758-765. PubMed ID: 31540818
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical use of bioelectrical impedance analysis in patients affected by myotonic dystrophy type 1: A cross-sectional study.
    Rinninella E; Silvestri G; Cintoni M; Perna A; Martorana GE; De Lorenzo A; Rossini PM; Miggiano GAD; Gasbarrini A; Mele MC
    Nutrition; 2019; 67-68():110546. PubMed ID: 31376676
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Outcome measures frequently used to assess muscle strength in patients with myotonic dystrophy type 1: a systematic review.
    Mateus T; Costa A; Viegas D; Marques A; Herdeiro MT; Rebelo S
    Neuromuscul Disord; 2022 Feb; 32(2):99-115. PubMed ID: 35031191
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies.
    Meola G
    Acta Myol; 2013 Dec; 32(3):154-65. PubMed ID: 24803843
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Survival patterns and cancer determinants in families with myotonic dystrophy type 1.
    Best AF; Hilbert JE; Wood L; Martens WB; Nikolenko N; Marini-Bettolo C; Lochmüller H; Rosenberg PS; Moxley RT; Greene MH; Gadalla SM
    Eur J Neurol; 2019 Jan; 26(1):58-65. PubMed ID: 30051542
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Uncovering health and social care needs among myotonic dystrophy patients: Utility of the Needs and Provisions Complexity Scale.
    Holmøy AKT; Johannessen CH; Hope S; van Walsem MR; Aanonsen NO; Hassel B
    Acta Neurol Scand; 2019 Jun; 139(6):526-532. PubMed ID: 30848487
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessment of muscular strength and functional capacity in the juvenile and adult myotonic dystrophy type 1 population: a 3-year follow-up study.
    Roussel MP; Fiset MM; Gauthier L; Lavoie C; McNicoll É; Pouliot L; Gagnon C; Duchesne E
    J Neurol; 2021 Nov; 268(11):4221-4237. PubMed ID: 33907889
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantitative Muscle MRI Depicts Increased Muscle Mass after a Behavioral Change in Myotonic Dystrophy Type 1.
    Heskamp L; Okkersen K; van Nimwegen M; Ploegmakers MJ; Bassez G; Deux JF; van Engelen BG; Heerschap A;
    Radiology; 2020 Oct; 297(1):132-142. PubMed ID: 32808888
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cognitive behavioural therapy for adults with dissociative seizures (CODES): a pragmatic, multicentre, randomised controlled trial.
    Goldstein LH; Robinson EJ; Mellers JDC; Stone J; Carson A; Reuber M; Medford N; McCrone P; Murray J; Richardson MP; Pilecka I; Eastwood C; Moore M; Mosweu I; Perdue I; Landau S; Chalder T;
    Lancet Psychiatry; 2020 Jun; 7(6):491-505. PubMed ID: 32445688
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Health-Related Quality of Life in Patients with Adult-Onset Myotonic Dystrophy Type 1: A Systematic Review.
    Landfeldt E; Edström J; Jimenez-Moreno C; van Engelen BGM; Kirschner J; Lochmüller H
    Patient; 2019 Aug; 12(4):365-373. PubMed ID: 30714084
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Affective symptoms and apathy in myotonic dystrophy type 1 a systematic review and meta-analysis.
    van der Velden BG; Okkersen K; Kessels RP; Groenewoud J; van Engelen B; Knoop H; Raaphorst J
    J Affect Disord; 2019 May; 250():260-269. PubMed ID: 30870776
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Patient-reported impact of symptoms in myotonic dystrophy type 1 (PRISM-1).
    Heatwole C; Bode R; Johnson N; Quinn C; Martens W; McDermott MP; Rothrock N; Thornton C; Vickrey B; Victorson D; Moxley R
    Neurology; 2012 Jul; 79(4):348-57. PubMed ID: 22786587
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Blood Transcriptome Profiling Links Immunity to Disease Severity in Myotonic Dystrophy Type 1 (DM1).
    Nieuwenhuis S; Widomska J; Blom P; 't Hoen PAC; van Engelen BGM; Glennon JC; On Behalf Of The Optimistic Consortium
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328504
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Feasibility and effects of a physical exercise programme in adults with myotonic dystrophy type 1: a randomized controlled pilot study.
    Kierkegaard M; Harms-Ringdahl K; Edström L; Widén Holmqvist L; Tollbäck A
    J Rehabil Med; 2011 Jul; 43(8):695-702. PubMed ID: 21670942
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects and Acceptability of an Individualized Home-Based 10-Week Training Program in Adults with Myotonic Dystrophy Type 1.
    Lessard I; Gaboury S; Gagnon C; Bouchard K; Chapron K; Lavoie M; Lapointe P; Duchesne E
    J Neuromuscul Dis; 2021; 8(1):137-149. PubMed ID: 33252090
    [TBL] [Abstract][Full Text] [Related]  

  • 60. What is known about the effects of exercise or training to reduce skeletal muscle impairments of patients with myotonic dystrophy type 1? A scoping review.
    Roussel MP; Morin M; Gagnon C; Duchesne E
    BMC Musculoskelet Disord; 2019 Mar; 20(1):101. PubMed ID: 30836978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.